Immunotherapy for Infectious Diseases Conference

Program


Day 1: November 12, 2018

Conference opening

7:30 — 8:30 am
Registration and breakfast
8:15 — 8:30 am
Welcome remarks by Dr. Magnus Hook and Dr. Zhiqiang An

Session 1: Antibody based drug development
Moderator: Livia Visai

8:30 — 9:20 am
John McCafferty, Keynote Speaker, Iontas Ltd.
Topic: Therapeutic Antibodies: Past, Present and Future
50 min
9:20 — 9:55 am
Michael Hust, Institute for Biochemistry, Biotechnology and Bioinformatics
Topic: Antibody phage display: generating antibodies for diagnostic and treatment of infectious diseases
35 min
9:55 — 10:30 am
Zhiqiang An, University of Texas Health Science Center
Topic: Antibody engineering: Humanization, affinity maturation and selection techniques
35 min
10:30 — 10:50 am
Break
20 min
10:50 — 11:25 am
Lynn Soong, The University of Texas Medical Branch
Topic: Immunobiology and Pathogenesis of Severe Scrub Typhus: Implications in Treatment
35 min
11:25 — Noon
Sumathi Nambiar, U.S. Food Drug and Administration
Topic: Regulatory Considerations in Development of Biologic Products
35 min
Noon — 2:00 pm
Lunch and poster session
2 hr

Session 2 : Immunotherapy against viral infections
Moderator: Zhiqiang An

2:00 — 2:35pm
Tong-Ming Fu, Merck
Topic: A Replication Defective Human Cytomegalovirus as a Vaccine to Prevent Congenital Infection and Disease
35 min
2:35 — 3:10pm
Mireia Pelegrin, Institut de Génétique Moléculaire de Montpellier
Topic: Vaccine-like effects of antiviral monoclonal antibodies: converting immunotherapies from passive to active
35 min
3:10 — 3:45 pm
Ann Leen, Texas Children’s Hospital
Topic: T-cell Therapy for Viruses
35 min
3:45 — 4:15 pm
Break
30 min
4:15 — 4:50 pm
Anna Honko, NIH
Topic: mAb Monotherapy Against Ebola Infection: Structure and Molecular Basis of Potent Protection
35 min
6:00 — 7:00 pm
Reception
7:30 pm
Dinner

Day 2: November 13, 2018

7:30 — 8:00 am
Breakfast
1 hr

Session 3 : Immunotherapy against emerging and neglected infectious disease
Moderator: Michael Hust

8:30 — 9:20 am
Gary Kobinger, Keynote speaker, Université Laval
Topic: The Assent Of mAbs Therapies Against Infectious Diseases
50 min
9:20 — 9:55 am
Qihui Wang, Chinese academy of sciences
Topic: Protective Antibodies Against Zika and Their Molecular Determinants
35 min
9:55 — 10:30 am
Luca Varani, Institute for research in biomedicine
Topic: Structure Based Antibody Engineering, Bispecifics Against Infectious Diseases
35 min
10:30 — 10:50 am
Break
20 min
10:50 — 11:25 am
Jeroen Pollet, Baylor College of Medicine
Topic: The Promise of RNA Vaccines Against Tropical and Emerging Infectious Diseases
35 min

Session 4: Immunotherapy against bacterial infections
Moderator: David Walker

11:25 — Noon
Bret Sellman, Medimmune
Topic: Bispecific Antibacterial Antibodies: A tale of Two Molecules
35 min
Noon — 2:00 pm
Lunch and poster session
2 hrs
2:00 — 2:35 pm
Wouter Hazenbos, Genentech
Topic: Antibody-antibiotic Conjugate: Mechanism and Modulation of Activity
35 min
2:35 — 3:10 pm
David Weiner, The Wistar Institute
Topic: Synthetic Nucleic Acid Technology for prevention and therapy of Infectious Diseases
35 min
3:10 — 3:45 pm
Marcos Pires, Lehigh University
Topic: Synthetic Agents that Remodel Bacterial Cell Surface for Antibody Recruitment
35 min
3:45 — 4:05 pm
Break
30 min
4:15 — 4:55 pm
Arnaud Avril, Institute of Biomedical research of the armed forces
Topic: Development Of Antibodies For Biodefense: The Example Of Anti-Botulinum Neurotoxins Antibodies
35 min
6:30 pm
Dinner

Day 3: November 14, 2018

7:30 — 8:00 am
Breakfast
1 hr

Session 5 : Emerging novel therapeutics showcase
Moderator: Zhiqiang An

8:30 — 9:05 am
Victor Nizet, , University of California
Topic: Repurposing FDA-Approved Drugs To Sensitize MDR Pathogens To Innate Immune Clearance
35 min
9:05 — 9:40 am
Burton Dickey, The University of Texas M. D. Anderson Cancer Center
Topic: Inducible Innate Airway Epithelial Resistance to Infection
35 min
10:15 — 10:35 am
Break
20 min

Session 6 : Selected poster talks
Moderator: Magnus Hook

9:40 — 10:00 am
Speaker 1
20 min
10:00 — 10:20 am
Speaker 2
20 min
10:20 — 10:35 am
Break
15 min
10:35 — 10:55 am
Speaker 3
20 min

Session 7 : Challenges of immunotherapy against infectious diseases
Moderator: Magnus Hook

10:55 — 11:25am
Panel Discussion
Lead: Steve Projan, Anti-infective Drug Discovery and Development Consultant
Panel: Steve Projan, Mark Benedyk, Burton Dickey
30 min
11:25 — 12:15 pm
Janice Reichert, Keynote Speaker, The Antibody Society
Topic: Anti-infective immunotherapy in context: State of the commercial clinical pipeline
50 min